Population stratiWcation may bias analysis of PGC-1α as a modiWer of age at Huntington disease motor onset

Eliana Marisa Ramos, Jeanne C. Latourelle, Ji Hyun Lee, Tammy Gillis, Jayalakshmi S. Mysore, Ferdinando Squitieri, Alba Di Pardo, Stefano Di Donato, Michael R. Hayden, Patrick J. Morrison, Martha Nance, Christopher A. Ross, Russell L. Margolis, Estrella Gomez-Tortosa, Carmen Ayuso, Oksana Suchowersky, Ronald J. Trent, Elizabeth McCusker, Andrea Novelletto, Marina FrontaliRandi Jones, Tetsuo Ashizawa, Samuel Frank, Marie Helene Saint-Hilaire, Steven M. Hersch, Herminia D. Rosas, Diane Lucente, Madaline B. Harrison, Andrea Zanko, Karen Marder, James F. Gusella, Jong Min Lee, Isabel Alonso, Jorge Sequeiros, Richard H. Myers, Marcy E. MacDonald

Résultat de rechercheexamen par les pairs

26 Citations (Scopus)

Résumé

Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by motor, cognitive and behavioral disturbances, caused by the expansion of a CAG trinucleotide repeat in the HD gene. The CAG allele size is the major determinant of age at onset (AO) of motor symptoms, although the remaining variance in AO is highly heritable. The rs7665116 SNP in PPARGC1A, encoding the mitochondrial regulator PGC-1α, has been reported to be a significant modiWer of AO in three European HD cohorts, perhaps due to affected cases from Italy. We attempted to replicate these Wndings in a large collection of (1,727) HD patient DNA samples of European origin. In the entire cohort, rs7665116 showed a significant effect in the dominant model (p value = 0.008) and the additive model (p value = 0.009). However, when examined by origin, cases of Southern European origin had an increased rs7665116 minor allele frequency (MAF), consistent with this being an ancestry-tagging SNP. The Southern European cases, despite similar mean CAG allele size, had a significantly older mean AO (p < 0.001), suggesting population-dependent phenotype stratiWcation. When the generalized estimating equations models were adjusted for ancestry, the effect of the rs7665116 genotype on AO decreased dramatically. Our results do not support rs7665116 as a modiWer of AO of motor symptoms, as we found evidence for a dramatic effect of phenotypic (AO) and genotypic (MAF) stratiWcation among European cohorts that was not considered in previously reported association studies. A significantly older AO in Southern Europe may reXect population diVerences in genetic or environmental factors that warrant further investigation.

Langue d'origineEnglish
Pages (de-à)1833-1840
Nombre de pages8
JournalHuman Genetics
Volume131
Numéro de publication12
DOI
Statut de publicationPublished - déc. 2012

Financement

Acknowledgments We thank the HD families, whose participation in genetic studies made this work possible, the COHORT co-investigators and contributors (see “Appendix”), contributors to the HD-MAPS study, Ruth Abramson, Alexandra Durr, Adam Rosenblatt, Luigi Frati, Susan Perlman, P. Michael Conneally, Mary Lou Klimek, Melissa Diggin, TiVany Hadzi and Ayana Duckett, as well as the Harvard Brain Tissue Resource Center at McLean Hospital and the National Neurological Research Specimen Bank at the VA West Los Angeles Healthcare Center. EMR is the recipient of a scholarship from the Fundação para a Ciência e a Tecnologia of Portugal (SFRH/BD/44335/2008). Study funding supported by NIH grants from the NINDS NS16367 (The Massachusetts HD Center Without Walls) and NS32765, and the CHDI Foundation, Inc.

Bailleurs de fondsNuméro du bailleur de fonds
Fundação para a Ciência e a Tecnologia of PortugalSFRH/BD/44335/2008
National Institutes of Health
National Institute of Neurological Disorders and StrokeR01NS032765, NS16367
CHDI Foundation

    ASJC Scopus Subject Areas

    • Genetics
    • Genetics(clinical)

    Empreinte numérique

    Plonger dans les sujets de recherche 'Population stratiWcation may bias analysis of PGC-1α as a modiWer of age at Huntington disease motor onset'. Ensemble, ils forment une empreinte numérique unique.

    Citer